Although the prognostic significance of hemoglobin (Hb) and RDW in cancer has been well-documented, both parameters are nonspecific and may be influenced by various non-neoplastic conditions including autoimmune disorders, hematologic diseases, and systemic inflammatory states. Here, GSTM1 is linked to hematologic disorder.